| Ryan M Burton, MD | |
|
1233 E 2nd St, Casper, WY 82601-2926 | |
| (307) 577-7201 | |
| Not Available |
| Full Name | Ryan M Burton |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 1233 E 2nd St, Casper, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275646093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ML20008196 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wyoming Medical Center | Casper, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wyoming Anesthesia, Llc | 8325383953 | 15 |
News Archive
Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal.
Bristol-Myers Squibb Company today announced updated survival data from the advanced melanoma cohort of Phase 1b study.
It is estimated that nearly 40 percent of women diagnosed with breast cancer will require a mastectomy. For those patients, breast reconstruction surgery is a valuable part of comprehensive breast cancer care as studies show it improves quality of life, self-esteem and sexuality.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
MedImmune has announced that its clinical program studying an investigational treatment targeting interleukin-9 (IL-9) has advanced with the start of a new trial in patients with asthma.
› Verified 5 days ago
| Entity Name | Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1669410643 PECOS PAC ID: 6608784194 Enrollment ID: O20061104000311 |
News Archive
Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal.
Bristol-Myers Squibb Company today announced updated survival data from the advanced melanoma cohort of Phase 1b study.
It is estimated that nearly 40 percent of women diagnosed with breast cancer will require a mastectomy. For those patients, breast reconstruction surgery is a valuable part of comprehensive breast cancer care as studies show it improves quality of life, self-esteem and sexuality.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
MedImmune has announced that its clinical program studying an investigational treatment targeting interleukin-9 (IL-9) has advanced with the start of a new trial in patients with asthma.
› Verified 5 days ago
| Entity Name | Wyoming Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265908321 PECOS PAC ID: 8325383953 Enrollment ID: O20181228002322 |
News Archive
Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal.
Bristol-Myers Squibb Company today announced updated survival data from the advanced melanoma cohort of Phase 1b study.
It is estimated that nearly 40 percent of women diagnosed with breast cancer will require a mastectomy. For those patients, breast reconstruction surgery is a valuable part of comprehensive breast cancer care as studies show it improves quality of life, self-esteem and sexuality.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
MedImmune has announced that its clinical program studying an investigational treatment targeting interleukin-9 (IL-9) has advanced with the start of a new trial in patients with asthma.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan M Burton, MD 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195-6340 Ph: () - | Ryan M Burton, MD 1233 E 2nd St, Casper, WY 82601-2926 Ph: (307) 577-7201 |
News Archive
Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal.
Bristol-Myers Squibb Company today announced updated survival data from the advanced melanoma cohort of Phase 1b study.
It is estimated that nearly 40 percent of women diagnosed with breast cancer will require a mastectomy. For those patients, breast reconstruction surgery is a valuable part of comprehensive breast cancer care as studies show it improves quality of life, self-esteem and sexuality.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
MedImmune has announced that its clinical program studying an investigational treatment targeting interleukin-9 (IL-9) has advanced with the start of a new trial in patients with asthma.
› Verified 5 days ago
David Barahal, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 W 2nd St, Suite 415, Casper, WY 82601 Phone: 307-237-5848 Fax: 307-237-5848 | |
Dr. Nathan G Putnam, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Anesthesiology, Casper, WY 82601 Phone: 435-720-2085 | |
Todd Michael Witzeling, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-577-2123 Fax: 307-577-2239 | |
Dr. Dustin J Roberts, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-577-2073 | |
Matthew V Foley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2345 E 3rd St, Casper, WY 82609 Phone: 307-689-6109 | |
Dr. Jeffery Steven Christensen, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 111 W 2nd St Ste 415, Casper, WY 82601 Phone: 307-237-5848 |